Author information from the last article
Seksjon for intensiv
Hjerteavdelingen
Haukeland universitetssjukehus
Bergen
Forfatterbidrag: Utarbeiding/revisjon av selve manuset og godkjenning av innsendte manusversjon.
Jørund Langørgen er ph.d. og tidligere overlege.
Articles by Jørund Langørgen
Pharmacy-dispensed drugs for secondary prevention after myocardial infarction
- Jarle Jortveit,
- Sigrun Halvorsen,
- Jørund Langørgen
09.03.2020:
Each year, approximately 13 000 Norwegians are hospitalised with acute myocardial infarction (1). Patients with established coronary artery disease are at increased risk of further cardiovascular events and premature mortality (2). Patients with a history of myocardial infarction are advised to...
A somnolent woman in her fifties with acute circulatory failure
- Jessica Viland,
- Jørund Langørgen,
- Øystein Wendelbo
27.05.2019:
A woman in her fifties with known hypertension and paroxysmal atrial fibrillation was admitted to hospital somnolent and hypotensive. ECG showed a broad complex cardiac rhythm with QRS width greater than 300 ms. A woman in her fifties was acutely hospitalised after being found unresponsive by...
Gender differences in the assessment and treatment of myocardial infarction
- Jarle Jortveit,
- Ragna Elise Støre Govatsmark,
- Jørund Langørgen,
- Torstein Hole,
- Jan Mannsverk,
- Siv Olsen,
- Cecilie Risøe,
- Sigrun Halvorsen
23.08.2016:
Each year, some 13 000 Norwegians are admitted to Norwegian hospitals with acute myocardial infarction (1). Several studies have shown that women may have less clear symptoms and clinical findings, wait longer for treatment, less frequently undergo invasive assessment and receive less secondary...
Should patients who use illicit drugs be offered a second heart-valve replacement?
- Ingrid Miljeteig,
- Steinar Skrede,
- Jørund Langørgen,
- Rune Haaverstad,
- Ola Jøsendal,
- Haakon Sjursen,
- Ole Frithjof Norheim
07.05.2013:
IVDUs are particularly prone to infectious endocarditis, with a lifetime incidence of 1 – 11 % (1, 2). Among the estimated 8 200 to 11 500 IVDUs living in Norway (3), there are indications of an increasing incidence of endocarditis with damage to the valves, as in other Western countries (4). At...
Hospital admission rates and case-fatality for cardiovascular diseases in Western Norway, 1992 - 2001
- Nina Øyen,
- Ottar Nygård,
- Jannicke Igland,
- Grethe S. Tell,
- Jan Erik Nordrehaug,
- Lorentz M. Irgens,
- John G. Cooper,
- Jørund Langørgen,
- Stein Emil Vollset
03.01.2008:
Since 1970, cardiovascular mortality (box 1) has decreased with more than 50 % in Norway and other Scandinavian countries (1, 2). A combination of several factors may have contributed to fewer patients acquiring disease (prevention) and/orfewer deaths (treatment) (2). Until recently, Norway has been...